NK
Naved Khan
About Naved Khan
Data last updated:
Naved Khan is a Director at Mercy Life Science Private Limited (since 2024). The companies operate in Paper and Healthcare. Mercy Life Science Private Limited reported revenue of ₹10.4 Lakh (FY 2025). Earlier, Naved Khan was a Director at Pharmiza Drugs Private Limited (2022–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mercy Life Science Private Limited U21001MP2024PTC069588 | Director | 31 Jan 2024 | 2024 | ₹10.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Pharmiza Drugs Private Limited U33100MP2022PTC062919 | Director | 29 Sep 2022 | 2022 | ₹1.47 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Naved Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mukund Ram Yadav | 10486817 | Mercy Life Science Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naved Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naved Khan
Naved Khan currently holds 1 directorship: Mercy Life Science Private Limited (Director, since 31 Jan 2024, revenue ₹10.4 Lakh (FY 2025)).
Naved Khan was first appointed on 29 Sep 2022 as Director at Pharmiza Drugs Private Limited. The most recent appointment on record is 31 Jan 2024 at Mercy Life Science Private Limited.
Naved Khan held 1 earlier board appointment: Pharmiza Drugs Private Limited (Director, 29 Sep 2022 to 18 Dec 2023).
The current boards of Naved Khan's companies include Mukund Ram Yadav (Mercy Life Science Private Limited).